News
For some people, eosinophilic fasciitis may heal without treatment in 2–5 years. People who need treatment may need to take a combination of steroids and immunosuppressants for 1–3 years.
If approved, Dupixent would be the first and only treatment indicated in the U.S. for children aged 1- 11 with eosinophilic esophagitis, a disease driven by type 2 inflammation that impacts the ...
Dupilumab (Dupixent) is the first FDA-approved treatment for children aged 1 to 11 years, weighing at least 15 kg, who have esophagitis eosinophilic (EoE). EoE is a chronic, progressive disease ...
Late-breaking presentation at ACG 2023 showed histologic and endoscopic improvements were maintained with no new safety signals to week 52 with higher dose Dupixent in these children Data ...
Eosinophilic esophagitis: How the drug Dupixent has improved treatment Written by Paul Ian Cross, PhD on January 3, 2024 — Fact checked by Jill Seladi-Schulman, Ph.D.
Eosinophilic fasciitis (EF) and its related dermatoses represent a challenging spectrum of rare inflammatory disorders typified by the progressive thickening of the fascia and overlying skin.
It is not known if DUPIXENT is safe and effective in children with eosinophilic esophagitis under 1 year of age, or who weigh less than 33 pounds (15 kg). to treat adults with prurigo nodularis (PN).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results